Long-term prognosis of acute myeloid leukaemia (AML) in patients above the age of 60 is still unsatisfactory, with 10-20% 5 year survival (Urbino I et al. Cancers 2021). New therapeutic approaches (particularly venetoclax + hypomethylating agents, CPX-351, gentuzumab ozogamicin + standard cytarabine/daunorubicine) look promising , however long term results are still lacking.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.